Connection

David Potter to Animals

This is a "connection" page, showing publications David Potter has written about Animals.
Connection Strength

0.743
  1. Ketamine: repurposing and redefining a multifaceted drug. Drug Discov Today. 2014 Dec; 19(12):1848-54.
    View in: PubMed
    Score: 0.035
  2. Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des. 2012; 18(37):6101-8.
    View in: PubMed
    Score: 0.029
  3. The opioidergic system: potential roles and therapeutic indications in the eye. J Ocul Pharmacol Ther. 2008 Apr; 24(2):117-40.
    View in: PubMed
    Score: 0.022
  4. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. CNS Drug Rev. 2005; 11(2):195-212.
    View in: PubMed
    Score: 0.018
  5. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther. 2004 May; 309(2):548-53.
    View in: PubMed
    Score: 0.017
  6. Delta-opioid agonist-stimulated inositol phosphate formation in isolated, rabbit iris-ciliary bodies: role of G(i/o) proteins and Gbetagamma-subunits. Exp Eye Res. 2003 Dec; 77(6):647-52.
    View in: PubMed
    Score: 0.017
  7. Changes in muscle proteins and spermidine content in response to unloading and clenbuterol treatment. Can J Physiol Pharmacol. 2003 Jan; 81(1):28-39.
    View in: PubMed
    Score: 0.015
  8. Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent. J Ocul Pharmacol Ther. 2002 Dec; 18(6):507-14.
    View in: PubMed
    Score: 0.015
  9. Pharmacological evidence of a role for prejunctional imidazoline (I(1)) receptors in ocular function. Curr Eye Res. 2002 Nov; 25(5):267-70.
    View in: PubMed
    Score: 0.015
  10. Ocular hypotension induced by electroacupuncture. J Ocul Pharmacol Ther. 2002 Aug; 18(4):293-305.
    View in: PubMed
    Score: 0.015
  11. Effect of hindlimb suspension and clenbuterol treatment on polyamine levels in skeletal muscle. Pharmacology. 2002 Jul; 65(3):145-54.
    View in: PubMed
    Score: 0.015
  12. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002 Jul; 65(3):155-61.
    View in: PubMed
    Score: 0.015
  13. Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats. Pharmacology. 2002 May; 65(1):38-48.
    View in: PubMed
    Score: 0.015
  14. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides. 2001 Oct-Dec; 35(5-6):232-7.
    View in: PubMed
    Score: 0.014
  15. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res. 2001 Aug; 73(2):167-78.
    View in: PubMed
    Score: 0.014
  16. Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics. Curr Eye Res. 2001 May; 22(5):358-66.
    View in: PubMed
    Score: 0.014
  17. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res. 2001 Mar; 72(3):331-9.
    View in: PubMed
    Score: 0.014
  18. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers. Chirality. 2000 Aug; 12(8):637-48.
    View in: PubMed
    Score: 0.013
  19. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist. J Pharmacol Exp Ther. 2000 Jun; 293(3):710-6.
    View in: PubMed
    Score: 0.013
  20. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res. 2000 May; 70(5):675-82.
    View in: PubMed
    Score: 0.013
  21. Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA. Biomed Chromatogr. 2000 Apr; 14(2):99-105.
    View in: PubMed
    Score: 0.013
  22. Potential sites of action of TNPA: a dopamine-2 receptor agonist. Exp Eye Res. 1999 Dec; 69(6):611-6.
    View in: PubMed
    Score: 0.013
  23. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action. Exp Eye Res. 1999 Aug; 69(2):227-38.
    View in: PubMed
    Score: 0.012
  24. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1745-52.
    View in: PubMed
    Score: 0.012
  25. Peripheral and central effects of naphazoline on ocular hydrodynamics. Involvement of imidazoline receptors, ANP, and Gi proteins. Ann N Y Acad Sci. 1999 Jun 21; 881:388-91.
    View in: PubMed
    Score: 0.012
  26. Intraocular pressure lowering by S-allylmercaptocysteine in rabbits. J Ocul Pharmacol Ther. 1999 Feb; 15(1):9-17.
    View in: PubMed
    Score: 0.012
  27. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis. Pharmacology. 1998 Nov; 57(5):249-60.
    View in: PubMed
    Score: 0.012
  28. Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine. J Ocul Pharmacol Ther. 1997 Dec; 13(6):489-96.
    View in: PubMed
    Score: 0.011
  29. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: role of cGMP. Pharmacology. 1997 Oct; 55(4):211-6.
    View in: PubMed
    Score: 0.011
  30. Oxymetazoline: potential mechanisms of inhibitory effects on aqueous humor dynamics. Pharmacology. 1996 Oct; 53(4):259-70.
    View in: PubMed
    Score: 0.010
  31. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996 Sep; 15(9):943-50.
    View in: PubMed
    Score: 0.010
  32. Elevation of intracellular Ca2+ concentration in rabbit nonpigmented ciliary epithelial cells by allicin. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Sep; 115(1):89-94.
    View in: PubMed
    Score: 0.010
  33. Ocular action of an opioid peptide, DPDPE. J Ocul Pharmacol Ther. 1996; 12(2):131-9.
    View in: PubMed
    Score: 0.010
  34. Centrally mediated ocular hypotension: potential role of imidazoline receptors. Ann N Y Acad Sci. 1995 Jul 12; 763:463-85.
    View in: PubMed
    Score: 0.009
  35. The central effects of moxonidine on intraocular pressure and its antagonism by L-659, 066 and L-657, 743 in the rabbit. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct; 18(6):1051-61.
    View in: PubMed
    Score: 0.009
  36. Ocular actions of moxonidine: a possible role for imidazoline receptors. J Pharmacol Exp Ther. 1994 Jun; 269(3):897-904.
    View in: PubMed
    Score: 0.009
  37. Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxin. Exp Eye Res. 1994 Jun; 58(6):729-36.
    View in: PubMed
    Score: 0.009
  38. Potential role of imidazoline (I1) receptors in modulating aqueous humor dynamics. J Ocul Pharmacol. 1994; 10(1):393-402.
    View in: PubMed
    Score: 0.008
  39. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther. 1993 Nov; 267(2):822-7.
    View in: PubMed
    Score: 0.008
  40. Ocular actions of an octahydrobenzo[f]quinoline: Ha117. Eur J Pharmacol. 1993 May 12; 236(1):61-8.
    View in: PubMed
    Score: 0.008
  41. Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits. J Ocul Pharmacol. 1993; 9(3):187-99.
    View in: PubMed
    Score: 0.008
  42. Allicin-induced hypotension in rabbit eyes. J Ocul Pharmacol. 1993; 9(3):201-9.
    View in: PubMed
    Score: 0.008
  43. Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors. Curr Eye Res. 1992 Oct; 11(10):963-70.
    View in: PubMed
    Score: 0.008
  44. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane. Invest Ophthalmol Vis Sci. 1991 Sep; 32(10):2799-805.
    View in: PubMed
    Score: 0.007
  45. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest Ophthalmol Vis Sci. 2011 Aug 16; 52(9):6452-61.
    View in: PubMed
    Score: 0.007
  46. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits. J Auton Pharmacol. 1990 Jun; 10(3):153-61.
    View in: PubMed
    Score: 0.006
  47. Prejunctional adrenoceptor activity of N-0437: a relatively selective DA2 dopamine receptor agonist. Eur J Pharmacol. 1990 Mar 27; 178(3):351-5.
    View in: PubMed
    Score: 0.006
  48. Review: alpha 2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential. J Ocul Pharmacol. 1990; 6(3):251-7.
    View in: PubMed
    Score: 0.006
  49. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol. 1990; 6(4):293-9.
    View in: PubMed
    Score: 0.006
  50. Functional evidence for heterogeneity of ocular alpha 2-adrenoceptors. Proc West Pharmacol Soc. 1990; 33:257-60.
    View in: PubMed
    Score: 0.006
  51. Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3853-9.
    View in: PubMed
    Score: 0.006
  52. Ocular and cardiac beta-antagonism by timolol prodrugs, timolol and levobunolol. Curr Eye Res. 1988 Aug; 7(8):755-9.
    View in: PubMed
    Score: 0.006
  53. Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology. 2008 Oct; 33(11):2676-87.
    View in: PubMed
    Score: 0.005
  54. LY141865: a relatively selective DA2 agonist with complex ocular activity. J Ocul Pharmacol. 1988; 4(1):19-28.
    View in: PubMed
    Score: 0.005
  55. Ocular effects of a N,N-disubstituted 5-OH aminotetralin (N-0437): evidence for a dual mechanism of action. Curr Eye Res. 1987 Nov; 6(11):1319-26.
    View in: PubMed
    Score: 0.005
  56. Aporphine derivatives affect ocular function in diverse ways. Curr Eye Res. 1987 Oct; 6(10):1227-36.
    View in: PubMed
    Score: 0.005
  57. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function. J Ocul Pharmacol. 1987; 3(4):309-21.
    View in: PubMed
    Score: 0.005
  58. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Curr Eye Res. 1986 Sep; 5(9):665-76.
    View in: PubMed
    Score: 0.005
  59. The ocular effects of xylazine in rabbits, cats, and monkeys. J Ocul Pharmacol. 1986; 2(1):9-21.
    View in: PubMed
    Score: 0.005
  60. Forskolin suppresses sympathetic neuron function and causes ocular hypotension. Curr Eye Res. 1985 Feb; 4(2):87-96.
    View in: PubMed
    Score: 0.004
  61. Mechanism of the ocular hypotensive action of ketanserin. J Ocul Pharmacol. 1985; 1(2):137-47.
    View in: PubMed
    Score: 0.004
  62. An in vivo model for dissociating alpha 2-and DA2-adrenoceptor activity in an ocular adnexa: utility of the cat nictitating membrane preparation. Curr Eye Res. 1984 Nov; 3(11):1289-98.
    View in: PubMed
    Score: 0.004
  63. Effects of aminotetralins on intraocular pressure and pupillary function in rabbits. J Auton Pharmacol. 1984 Sep; 4(3):185-92.
    View in: PubMed
    Score: 0.004
  64. Alteration in ocular function induced by phenylethylamine analogs of dopamine. Curr Eye Res. 1984 Jun; 3(6):851-9.
    View in: PubMed
    Score: 0.004
  65. Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment. Curr Eye Res. 1984 Feb; 3(2):307-14.
    View in: PubMed
    Score: 0.004
  66. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr Eye Res. 1982-1983; 2(5):281-8.
    View in: PubMed
    Score: 0.004
  67. Ocular hypertensive response to beta-adrenoceptor agonists. Curr Eye Res. 1982-1983; 2(10):711-9.
    View in: PubMed
    Score: 0.004
  68. Effects of ethanol, acetaldehyde and acetate on insulin release from perifused pancreatic islets. Pharmacology. 1982; 24(5):314-20.
    View in: PubMed
    Score: 0.004
  69. Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats. Cells Tissues Organs. 2002; 171(2-3):188-98.
    View in: PubMed
    Score: 0.004
  70. Adrenergic pharmacology of aqueous humor dynamics. Pharmacol Rev. 1981 Sep; 33(3):133-53.
    View in: PubMed
    Score: 0.004
  71. Steric structure activity relationships of various adrenergic agonists: ocular and systemic effects. Curr Eye Res. 1981; 1(1):25-35.
    View in: PubMed
    Score: 0.003
  72. Adrenergic drugs and intraocular pressure. Gen Pharmacol. 1981; 12(1):1-13.
    View in: PubMed
    Score: 0.003
  73. The effects of topical prazosin on normal and elevated intraocular pressure and blood pressure in rabbits. Eur J Pharmacol. 1980 Jun 27; 64(4):361-3.
    View in: PubMed
    Score: 0.003
  74. Adrenergic drugs and intraocular pressure: suppression of ocular hypertension induced by water loading. Exp Eye Res. 1980 Jan; 30(1):93-104.
    View in: PubMed
    Score: 0.003
  75. Acute pretreatment with pyrazole and ethanol: effects on glucose-induced changes in insulin and glucagon. Pharmacology. 1980; 20(4):203-10.
    View in: PubMed
    Score: 0.003
  76. The influence of endogenous glucagon release on hyperglycemic responses to catecholamines in normal fed and diabetic rats. J Pharmacol Exp Ther. 1979 Sep; 210(3):458-64.
    View in: PubMed
    Score: 0.003
  77. Effects of adrenergic drugs on aqueous cAMP and cGMP and intraocular pressure. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979; 212(2):65-75.
    View in: PubMed
    Score: 0.003
  78. Adrenergic drugs and intraocular pressure: effects of selective beta-adrenergic agonists. Exp Eye Res. 1978 Dec; 27(6):615-25.
    View in: PubMed
    Score: 0.003
  79. Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons. Pharmacology. 1978; 17(4):221-6.
    View in: PubMed
    Score: 0.003
  80. Changes in plasma glucose and insulin levels induced by adrenergic agents in normal and alloxan-diabetic rats. Proc Soc Exp Biol Med. 1977 Mar; 154(3):337-40.
    View in: PubMed
    Score: 0.003
  81. Catecholamine-induced changes in plasma glucose and insulin levels in the unanesthetized rabbit. Pharmacology. 1977; 15(5):407-14.
    View in: PubMed
    Score: 0.003
  82. Modification of polypeptide activity by cysteine analogs: structure-activity relationship. Pharmacology. 1971; 5(6):359-71.
    View in: PubMed
    Score: 0.002
  83. Effects of ibuterol, a beta-2 adrenergic prodrug, on intraocular pressure. J Ocul Pharmacol. 1986; 2(3):225-37.
    View in: PubMed
    Score: 0.001
  84. Circadian rhythm in intraocular pressure: a rabbit model. Curr Eye Res. 1981; 1(3):169-73.
    View in: PubMed
    Score: 0.001
  85. Taurine concentrations in the aqueous humor and plasma of anesthetized rabbits. Experientia. 1980 Aug 15; 36(8):980-1.
    View in: PubMed
    Score: 0.001
  86. Isoproterenol- and epinephrine-induced changes in blood glucose and tissue glycogen levels in normal and diabetic rats: the influence of alteration in endogenous insulin levels and state of nourishment. J Pharmacol Exp Ther. 1975 May; 193(2):576-84.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.